The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1527-3350|61|5|1555-1564

ISSN： 0270-9139

Source： HEPATOLOGY, Vol.61, Iss.5, 2015-05, pp. : 1555-1564

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Luseogliflozin improves liver fat deposition compared to metformin in type 2 diabetes patients with non‐alcoholic fatty liver disease: A prospective randomized controlled pilot study

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. 2, 2018-02 ,pp. : 438-442

John Wiley & Sons Inc

Access to resources Recommend Favorite

Liver volume in humans

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 2, 2015-01 ,pp. : 210-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of efficacy of low‐carbohydrate and low‐fat diet education programs in non‐alcoholic fatty liver disease: A randomized controlled study

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 3, 2018-02 ,pp. : E22-E29

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non-alcoholic fatty liver disease

By Smith Briohny W.   Adams Leon A.  

Critical Reviews in Clinical Laboratory Sciences, Vol. 48, Iss. 3, 2011-06 ,pp. : 97-113

Informa Healthcare

Access to resources Recommend Favorite

Nonalcoholic fatty liver disease in women

By Suzuki Ayako   Abdelmalek Manal F  

Women's Health, Vol. 5, Iss. 2, 2009-03 ,pp. : 191-203

Future Medicine

Access to resources Recommend Favorite